Suppr超能文献

药物诱导大鼠排便:中枢5-羟色胺1A受体的作用

Drug-induced defaecation in rats: role of central 5-HT1A receptors.

作者信息

Croci T, Landi M, Bianchetti A, Manara L

机构信息

SANOFI-MIDY S.p.A. Research Center, Milan, Italy.

出版信息

Br J Pharmacol. 1995 May;115(1):203-9. doi: 10.1111/j.1476-5381.1995.tb16340.x.

Abstract
  1. We investigated the acute effects of 5-hydroxytryptamine (5-HT), and of the 5-HT1A receptor agonists, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), buspirone and SR 57746A, on rat faecal pellet output and water content. 2. 5-HT, 8-OH-DPAT, buspirone and SR 57746A, a new selective 5-HT1A receptor agonist, displaced [3H]-8-OH-DPAT from specific binding sites in rat hippocampus membranes (Ki, nM; 1.8, 1.2, 15, 3.1 respectively) and stimulated rat defaecation dose-dependently. SR 57746A and buspirone induced 1 g dry weight of faeces at 1.3 and 6.1 mg kg-1, p.o. (AD1) respectively. 8-OH-DPAT and 5-HT stimulated defaecation after s.c. injection (AD1, 0.07 and 7.5 mg kg-1, respectively). All these agents increased faecal water content. 3. The putative 5-HT1A receptor antagonist, pindolol, injected s.c. or i.c.v., significantly reduced the defaecation induced by systemically administered 8-OH-DPAT, buspirone or SR 57746A, but not 5-HT. 4. Pretreatment with p-chlorophenylalanine (i.p.) or 5,7-dihydroxytryptamine (i.c.v.), according to protocols designed to cause either generalized or CNS-limited 5-HT depletion respectively, also reduced the defaecation induced by buspirone or SR 57746A. 5. No specific 5-HT1A binding sites could be labelled by incubating rat colon membranes with [3H]-8-OH-DPAT, and in vitro preparations of rat colon segments showed no response to 8-OH-DPAT or SR 57746A up to 5 microM. 6. After eight days' repeated daily treatment, complete tolerance developed to the stimulant effects of SR 57746A and buspirone on faecal water content, but not on faecal pellet output. This suggests that faecal mass excretion and water exchange through the gut wall are affected by independent mechanisms.7. The present findings support the involvement of central 5-HTIA receptors in intestinal propulsion and regulation of luminal fluid content, presumably accounting for the drug-induced defaecation in rats.
摘要
  1. 我们研究了5-羟色胺(5-HT)以及5-HT1A受体激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)、丁螺环酮和SR 57746A对大鼠粪便颗粒排出量和含水量的急性影响。2. 5-HT、8-OH-DPAT、丁螺环酮以及新型选择性5-HT1A受体激动剂SR 57746A均可使[3H]-8-OH-DPAT从大鼠海马膜中的特异性结合位点上解离(Ki,nM;分别为1.8、1.2、15、3.1),并剂量依赖性地刺激大鼠排便。SR 57746A和丁螺环酮经口服给药(AD1),分别在剂量为1.3和6.1 mg·kg-1时可诱导产生1 g干重的粪便。8-OH-DPAT和5-HT经皮下注射后可刺激排便(AD1分别为0.07和7.5 mg·kg-1)。所有这些药物均增加了粪便含水量。3. 假定的5-HT1A受体拮抗剂吲哚洛尔经皮下或脑室内注射后,可显著降低全身给药的8-OH-DPAT、丁螺环酮或SR 57746A所诱导的排便,但对5-HT诱导的排便无影响。4. 根据分别旨在导致全身或中枢神经系统局限性5-HT耗竭的方案,用对氯苯丙氨酸(腹腔注射)或5,7-二羟基色胺(脑室内注射)进行预处理,也可降低丁螺环酮或SR 57746A所诱导的排便。5. 用[3H]-8-OH-DPAT孵育大鼠结肠膜无法标记出特异性5-HT1A结合位点,并且大鼠结肠段的体外制备物在高达5 μM的浓度下对8-OH-DPAT或SR 57746A均无反应。6. 经过为期八天的每日重复治疗后,对SR 57746A和丁螺环酮对粪便含水量的刺激作用产生了完全耐受性,但对粪便颗粒排出量无耐受性。这表明粪便质量排泄和通过肠壁的水分交换受独立机制的影响。7. 目前的研究结果支持中枢5-HT1A受体参与肠道推进和管腔液含量调节,这可能是药物诱导大鼠排便的原因。

相似文献

本文引用的文献

3
SR 48968 selectively prevents faecal excretion following activation of tachykinin NK2 receptors in rats.
J Pharm Pharmacol. 1994 May;46(5):383-5. doi: 10.1111/j.2042-7158.1994.tb03819.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验